SCHEMBL30360600

SCHEMBL30360600

Cn1c(-c2ccc(S(C)(=O)=O)cc2)cc2ncc(-c3ccc(N4CCN5CCCC5C4)cc3)cc21

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 1/20 0.45
▸ HTR6 P50406 6/20 0.43
▸ MAP4K1 Q92918 1/20 0.41
▸ PIK3CA P42336 1/20 0.38
▸ PRKDC P78527 1/20 0.38
▸ RAD52 P43351 1/20 0.38
▸ LRRK2 Q5S007 2/20 0.36
▸ KDM2B Q8NHM5 1/20 0.36
▸ GPR119 Q8TDV5 2/20 0.36
▸ ADCY5 O95622 1/20 0.36
▸ PTGS1 P23219 1/20 0.36
▸ PTGS2 P35354 1/20 0.36
▸ ACVR1 Q04771 1/20 0.36
▸ JAK2 O60674 1/20 0.36
▸ JAK3 P52333 1/20 0.36
▸ PTK2 Q05397 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26516668 1.00 HRH3 (0.45) HRH3HTR6MAP4K1PIK3CAPRKDC
SCHEMBL26516735 0.89 HRH3 (0.41) HRH3HTR6MAP4K1PIK3CAPRKDC
SCHEMBL30360625 0.89 HRH3 (0.41) HRH3HTR6MAP4K1PIK3CAPRKDC
SCHEMBL26516667 0.82 MAP4K1 (0.39) MAP4K1PIK3CAPRKDCRAD52LRRK2
SCHEMBL26516681 0.81 MAP4K1 (0.41) MAP4K1RAD52LRRK2GPR119ACVR1
SCHEMBL29006623 0.81 MAP4K1 (0.41) MAP4K1RAD52LRRK2GPR119ACVR1
SCHEMBL26516674 0.81 MAP4K1 (0.41) MAP4K1RAD52LRRK2GPR119ACVR1
SCHEMBL30360601 0.80 MAP4K1 (0.47) HRH3MAP4K1PIK3CARAD52LRRK2
SCHEMBL26516557 0.80 MAP4K1 (0.47) HRH3MAP4K1PIK3CARAD52LRRK2
SCHEMBL30360598 0.80 MAP4K1 (0.48) MAP4K1RAD52ACVR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4200015-A1 SUBSTITUTED HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF TLR9 Bristol-Myers Squibb Company (US) 2023-06-28 — — EP claimed
CN-115956077-A Substituted heteroaryl compounds as TLR9 inhibitors 百时美施贵宝公司 2023-04-11 — — CN claimed
Send feedback